Clinical Trial Update: Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14. [Phase 2]

View source ↗

Summary

Phase 2 trial update on BURKIMAB-14 investigating treatment for mature B-ALL and Burkitt lymphoma in adults; current status unavailable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Mature B-cell Leukemia Burkitt Type

Drugs mentioned

• BURKIMAB (burkimumab)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Mature B-Cell Leukemia Burkitt Type, Burkitt Lymphoma (BL) | Phase 2 | Status: UNKNOWN